Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_assertion type Assertion NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_head.
- NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_assertion description "[Notably, they suggest that Grb2 may represent a promising target for the design of novel CRC therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_provenance.
- NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_assertion evidence source_evidence_literature NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_provenance.
- NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_assertion SIO_000772 24708867 NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_provenance.
- NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_assertion wasDerivedFrom befree-2016 NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_provenance.
- NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_assertion wasGeneratedBy ECO_0000203 NP1171122.RA9wbjygb1VYsQIPH_0IDuuN2BkR2-vAlAXR80gft1SF8130_provenance.